Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Search for stocks (e.g., AAPL, GOOGL, AMZN)
AYTU logo

AYTU

NSC
Aytu BioPharma Inc.
HealthcareBiotechnology
Watchlists:
Last updated: Friday 11th July 2025
2.29
-0.07 (-2.97%)
Prev Close:2.36
Open:2.4
Bid:2.27
Ask:2.41
52 Week Range
0.95
2.87
Volume:1,353,193
Mkt Cap:14 M
Price Target
$2.63
+14.8%
Financials

Financial Statements

AYTU - Income Statement (Annual)

Jun-24Jun-23Jun-22Jun-21Jun-20Jun-19Jun-18Jun-17Jun-16Jun-15
Acquisition Expense3 M2 M
Depreciation And Amortization5 M5 M6 M6 M13 M2 M2 M2 M664707.090662.0
Development Expense36 M
Earnings From Equity Interest212809.0
Earnings From Equity Interest Net Of Tax212809.0
Fees20000.020000.0
Gain On Sale Of Business-10 M
Gain On Sale Of PPE100000.0100000.0-100000.080779.04 M
Gain On Sale Of Security-4 M5 M2 M2000.0-16000.0-1 M-61519.0-971629.0
General And Administrative Expense23 M29 M31 M26 M20 M-100000.0-142000.0-139000.0-120000.0-51000.0
Gross Profit Margin (profit Margin After CGS)55 M67 M52 M29 M19 M5 M-2 M-2 M1 M-137331.0
Impairment Of Capital Assets6 M66 M13 M200000.02 M1 M8 M
Interest Expense Non Operating5 M9000.014000.06000.03 M535500.0749423.03 M5 M114994.0
Interest Income Operating-12572.0
Minority Interests44 M138 M
Misc Other Special Charges568000.0184000.0-588000.0840000.0-3 M7 M10 M3 M620325.0620325.0
Net Income (loss)-16 M-17 M-109 M-58 M-14 M-27 M-10 M-23 M-28 M-8 M
Net Income Common Stockholders-16 M-17 M-109 M-58 M-14 M-27 M-10 M-23 M-28 M-8 M
Net Income Continuous Operations-16 M-17 M-109 M-58 M-14 M-27 M-10 M-23 M-28 M-8 M
Net Non Operating Interest Income Expense-9000.0-14000.0-6000.08 M-10 M-749423.0-3 M-5 M-114994.0
Net Operating Interest Income Expense-114994.0
Operating Income-5 M-17 M-110 M-59 M-21 M-17 M-22 M-22 M-14 M-8 M
Operating Income Before Depreciation (EBITDA)-5 M-8 M-26 M-29 M-12 M-24 M-7 M-15 M-17 M-7 M
Operating Expense60 M84 M88 M88 M40 M-24 M-23 M-23 M-24 M-8 M
Other Gand A23 M29 M31 M26 M20 M-100000.0-142000.0-139000.0-120000.0-51000.0
Other Impairment Of Capital Assets6 M10 M195278.0
Other Operating Expenses-361000.0-246000.02 M-2000.0208000.0387960.0191991.0203992.0
Other Write Off-13 M-11 M
Promotion And Advertising5 M17 M14 M15 M5 M
Rent And Landing Fees-200000.0-100000.0-142000.0-139000.0-120000.0-51000.0
Research Expense3 M4 M13 M6 M2 M589072.0167595.0959857.06 M3 M
Restructring And Mn A Income2 M44 M5 M700000.038 M-2 M-6 M-6 M
Salaries And Wages3 M6 M5 M-4 M-400000.0-1 M-597000.0-3 M-903000.0203992.0
Selling And Marketing Expense27 M41 M39 M30 M11 M19 M18 M17 M9 M4 M
Selling Expense30 M35 M19 M18 M17 M9 M4 M
Total Income Available For Interest Expense (EBIT)-9 M-17 M-36 M-38 M-18 M-27 M-9 M-20 M-23 M-8 M
Total Revenues81 M107 M97 M66 M28 M7 M4 M3 M3 M261782.0
Total Expenses86 M124 M133 M125 M42 M-26 M-25 M-25 M-25 M-8 M
Total Revenue81 M107 M97 M66 M28 M7 M4 M3 M3 M261782.0
Amord5 M5 M6 M6 M4 M2 M2 M2 M664707.090662.0
Avgshs6 M3 M1 M837333.0225960.038972.0665605.023301.021.0115.0
Avgshsdt6 M3 M1 M837333.0225960.038982.0665438.023300.021.0114.0
Basiceps-2.86-5.11-67.8-74.0
Basicepscont-2.86-5.11-67.8
Cor26 M41 M44 M36 M8 M-2 M-2 M-1 M-957076.0-88109.0
Depamor7 M7 M6 M600000.013 M-100000.0-294000.0-134000.0-51000.0-27000.0
Dileps-2.86-5.11-75.0-69.6-60.0-696.0-15.31-966.0-1 M-67200.0
Dilepscont-5.11-75.0-69.6-60.0
Intinc10 M-10 M
Netincdisc-16 M-17 M-109 M-58 M-14 M-27 M-10 M-23 M-28 M-8 M
Othincexp3 M-6 M-73 M-840000.0-8 M-80779.0-14 M-3 M971629.0-1 M
Pretaxinc-14 M-17 M-109 M-58 M-14 M-27 M-10 M-23 M-28 M-8 M
Resdev3 M4 M13 M42 M2 M589072.0167595.0959857.06 M3 M
Restruct2 M44 M5 M700000.038 M-2 M-6 M-6 M
Sga49 M70 M70 M56 M31 M19 M18 M17 M9 M4 M
Shsout6 M6 M3 M1 M629186.088440.02 M50.0172.0172.0
Specincchg-2 M-6 M-66 M-18 M-900000.0-38 M-2 M-1 M-7 M6 M
Taxprov2 M-430000.0-110000.0259000.0-798000.0-192000.0-101000.0-100000.0-6000.0-23910.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader